Published on
05:46 GMT
Indian pharma well positioned despite tariff threats, says Sandip Sabharwal
"So, valuations, even after these falls are excessive for these companies, like some of these smaller companies trade at valuation even now after a 50% drop which is higher than of Titan, I do not think they deserve that," says Sandip Sabharwal, …
Source:
The Economic Times
-
Center-right
